Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1668651

registered interest
date	08/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Women
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they will take to address factors contributing to higher HIV transmission rates among marginalised women, such as sex workers, transgender women, and immigrants.
tabling member printed	Baroness Barker
uin	HL87
answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>The HIV Action Plan is the cornerstone of our approach in England to drive forward progress and achieve our goal to end new HIV transmissions, AIDS and HIV-related deaths within England by 2030. A key principle of our approach is to ensure that all underserved populations benefit equally from improvements made in HIV outcomes, including marginalised women. This includes scaling up HIV testing in targeted, high-risk populations and increasing equitable access to and use of HIV pre-exposure prophylaxis (PrEP).</p><p>Initial analysis recently published by the UK Health Security Agency show that HIV opt-out testing in emergency departments in local authority areas with extremely high HIV prevalence has been particularly successful at reaching women with HIV testing. The HIV Action Plan Implementation Steering Group is developing a roadmap to help guide our efforts to improve equitable access, uptake and use of PrEP to meet the needs of key populations at significant risk of HIV, including heterosexual and transgender women, which is expected to be made available by the end of the year.</p><p>HIV Prevention England delivers a nationally co-ordinated programme of HIV prevention work designed to complement locally commissioned HIV prevention in areas with high HIV prevalence and for communities at risk of HIV transmission, with a particular focus on women, and includes the promotion of evidence-based HIV prevention interventions such as condom use.</p> answering member printed Lord Markham grouped question UIN HL88 question first answered 20/11/2023 14:15:20 answering member 4948 label Biography information for Lord Markham
tabling member	2501 label Biography information for Baroness Barker

1668652

registered interest
date	08/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Women
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they will take to ensure that women have control over their sexual and reproductive health decisions through empowering them to (1) negotiate condom use, (2) access pre-exposure prophylaxis (PrEP), and (3) make informed choices to prevent HIV transmission.
tabling member printed	Baroness Barker
uin	HL88
answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>The HIV Action Plan is the cornerstone of our approach in England to drive forward progress and achieve our goal to end new HIV transmissions, AIDS and HIV-related deaths within England by 2030. A key principle of our approach is to ensure that all underserved populations benefit equally from improvements made in HIV outcomes, including marginalised women. This includes scaling up HIV testing in targeted, high-risk populations and increasing equitable access to and use of HIV pre-exposure prophylaxis (PrEP).</p><p>Initial analysis recently published by the UK Health Security Agency show that HIV opt-out testing in emergency departments in local authority areas with extremely high HIV prevalence has been particularly successful at reaching women with HIV testing. The HIV Action Plan Implementation Steering Group is developing a roadmap to help guide our efforts to improve equitable access, uptake and use of PrEP to meet the needs of key populations at significant risk of HIV, including heterosexual and transgender women, which is expected to be made available by the end of the year.</p><p>HIV Prevention England delivers a nationally co-ordinated programme of HIV prevention work designed to complement locally commissioned HIV prevention in areas with high HIV prevalence and for communities at risk of HIV transmission, with a particular focus on women, and includes the promotion of evidence-based HIV prevention interventions such as condom use.</p> answering member printed Lord Markham grouped question UIN HL87 question first answered 20/11/2023 14:15:20 answering member 4948 label Biography information for Lord Markham
tabling member	2501 label Biography information for Baroness Barker

1668656

registered interest
date	08/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what action they plan to take to resolve the shortages of more than 100 medicines, as reported by the British Generic Manufacturers Association.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL92
answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>Medicine supply problems can occur for several reasons. For example, they can be due to manufacturing difficulties, regulatory problems, problems with the supply of raw materials, sudden demand spikes or from issues which are related to the distribution of the product. The production of medicines is complex and highly regulated, and materials and processes must meet rigorous safety and quality standards. Occasionally, the National Health Service experiences temporary shortages of specific medicines.</p><p> </p><p>We know how frustrating and distressing the possibility of shortages can be and we acknowledge that there have been challenges recently with access to a limited number of medicines. We want to assure patients that the Department has well-established processes to prevent, manage and mitigate medicine shortages and works with the pharmaceutical industry, the Medicines and Healthcare products Regulatory Agency, NHS England, the devolved governments and others operating in the supply chain to help ensure patients have access to the treatments they need.</p><p> </p><p>The Department routinely shares information about medicine supply issues directly with the NHS so they can put management plans in place to mitigate the risk of the shortage impacting patients and inform their patients about what it might mean for them. If any patient is concerned about their treatment, they should discuss this with their pharmacist or general practitioner.</p> answering member printed Lord Markham question first answered 20/11/2023 14:08:02 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1668658

registered interest
date	08/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Health Education
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they are planning to implement comprehensive public education campaigns to raise awareness about HIV transmission and treatment advancements, and to tackle stigma; and, if so, what are their plans.
tabling member printed	Lord Black of Brentwood
uin	HL95
answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>HIV Prevention England (HPE) is the national HIV prevention programme for England and is funded at £3.5 million by the Department. The programme aims to support communities who are disproportionately affected by HIV, including gay, bisexual and men who have sex with men and Black African heterosexual men and women. The Department has appointed Terrence Higgins Trust, a national charity who provide services related to sexual heath and HIV, to deliver the programme from 2021 to 2024. HPE delivers a nationally co-ordinated programme of HIV prevention work, including public campaigns such as National HIV Testing Week, that is designed to complement locally commissioned prevention activities in areas of high HIV prevalence. HPE also aims to improve knowledge and understating of HIV transmission and reducing stigma within affected communities.</p><p>HPE works with a wide range of models and their network of influencers and develops its strategies based on comprehensive data, audience insight and knowledge from local partners within England which ensure a wide range of patient’s voices and experiences are represented.</p> answering member printed Lord Markham grouped question UIN HL97 question first answered 20/11/2023 14:09:38 answering member 4948 label Biography information for Lord Markham
tabling member	4171 label Biography information for Lord Black of Brentwood

1668662

registered interest
date	08/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Staff
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they have made representations to the Chief Executive of NHS England about the appropriateness of employing NHS staff who have supported calling for (1) a Jihad, or (2) the destruction of Israel.
tabling member printed	Lord Blencathra
uin	HL100
answer	answer is ministerial correction date of answer 22/11/2023 answer text <p>The Secretary of State has not made representations to the Chief Executive of NHS England about the appropriateness of employing National Health Service staff who have supported calling for a Jihad, or the destruction of Israel.</p> answering member printed Lord Markham question first answered 22/11/2023 12:42:18 answering member 4948 label Biography information for Lord Markham
tabling member	497 label Biography information for Lord Blencathra

1668071

registered interest
date	07/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	IVF: LGBT+ People
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that same-sex couples have equal access to IVF provision.
tabling member printed	Baroness Deech
uin	HL22
answer	answer is ministerial correction date of answer 14/11/2023 answer text <p>Funding decisions for health services in England, including in vitro fertilisation (IVF), are made by integrated care boards (ICBs) and are based on the clinical needs of their local population.</p><p>The Government published the first Women’s Health Strategy on 20 July 2022, which contained several important changes and future ambitions to improve the variations in access to National Health Service funded fertility services. This includes improving access to IVF for female same-sex couples by removing the additional financial burden they face when accessing treatment. NHS England are developing guidance for ICBs to assist in their commissioning plans, which will be published shortly.</p> answering member printed Lord Markham question first answered 14/11/2023 16:52:09 answering member 4948 label Biography information for Lord Markham
tabling member	3756 label Biography information for Baroness Deech

1668073

registered interest
date	07/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fertility: Medical Treatments
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they take to monitor disparities in access to fertility treatment caused by local health authorities, in particular surrounding access of same-sex couples to treatment.
tabling member printed	Baroness Deech
uin	HL23
answer	answer is ministerial correction date of answer 14/11/2023 answer text <p>As part of the first-year commitments in the Women’s Health Strategy, we published our in-vitro fertilisation (IVF) transparency tool on GOV.UK in July 2023. This tool compiles published integrated care board policies on their local fertility treatment offer, to inform patients, to keep track nationally of implementation progress, and to highlight poor performers.</p> answering member printed Lord Markham question first answered 14/11/2023 16:50:35 answering member 4948 label Biography information for Lord Markham
tabling member	3756 label Biography information for Baroness Deech

1668074

registered interest
date	07/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fertility: Medical Treatments
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they have any plans to develop a national tariff for fertility treatment in order to achieve a strategy to achieve best value for the NHS.
tabling member printed	Baroness Deech
uin	HL24
answer	answer is ministerial correction date of answer 13/11/2023 answer text <p>A benchmark price for in-vitro fertilisation and intracytoplasmic sperm injection remains part of the new NHS Payment Scheme. There are no current plans to develop a national tariff for these treatments.</p> answering member printed Lord Markham question first answered 13/11/2023 17:51:09 answering member 4948 label Biography information for Lord Markham
tabling member	3756 label Biography information for Baroness Deech

1668075

registered interest
date	07/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the National Institute for Health and Care Excellence (NICE) guidelines Fertility problems: assessment and treatment, published on 20 February 2013 and updated on 6 September 2017, what assessment they have made of the access criteria for IVF.
tabling member printed	Baroness Deech
uin	HL25
answer	answer is ministerial correction date of answer 14/11/2023 answer text <p>The National Institute for Health and Care Excellence (NICE) fertility guidelines are currently under review by NICE, who expects revised guidelines to be published by the end of 2024.</p><p>The Women’s Health Strategy sets out our longer-term ambition to work with NHS England and integrated care boards to ensure that the recommendations of the revised guidelines are fully implemented.</p> answering member printed Lord Markham question first answered 14/11/2023 16:52:42 answering member 4948 label Biography information for Lord Markham
tabling member	3756 label Biography information for Baroness Deech

1668101

registered interest
date	07/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Finance
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, in each year since 2014, how much funding they provided to community pharmacies in retained margin in real terms as part of the Community Pharmacy Contractual Framework; and what was the cost of medicines bought by community pharmacies.
tabling member printed	Baroness Merron
uin	HL55
answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>The retained medicine margin as allowed under the Community Pharmacy Contractual Framework funding for years 2014/15 to 2021/22 was £800 million per year; for 2022/23 and 2023/24 it is £850 million. The Department does not hold the cost information requested as our data refers to the whole of primary care and we do not have figures for community pharmacy only</p> answering member printed Lord Markham question first answered 20/11/2023 12:14:06 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron